Generic Injectables Market Size & Share | Global Trends 2021, 28
The generic injectables market is projected to reach US$ 150.65 billion by 2028 from US$ 74.74 billion in 2021; it is expected to register a CAGR of 10.5% from 2021 to 2028.
Generic injectables are the bioequivalents of their branded counterparts and are not protected by patents. They are safe and effective as the innovator drugs since they have similar active ingredients, dosages, strength, qualities, form, etc.
The report offers insights and in-depth analysis of the generic injectables market, emphasizing various parameters such as market trends, technological advancements, and market dynamics; it also provides the competitive landscape analysis of leading market players and the impact of the COVID-19 pandemic on the market across all major regions. The COVID-19 pandemic has disrupted the socioeconomic conditions of various countries across the world. As per the recent WHO statistics, the US is the world's worst-affected country due to the pandemic with the highest number of cases. The high number of COVID cases has negatively impacted the economy of the US, and consequently that of North America. There has been a decline in overall business activities and growth of various industries operating in the region.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Generic Injectables Market: Strategic Insights
Market Size Value in US$ 74.74 billion in 2021 Market Size Value by US$ 150.65 billion by 2028 Growth rate CAGR of 10.5% from 2021 to 2028 Forecast Period 2021- 2028 Base Year 2021
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Generic Injectables Market: Strategic Insights
| Market Size Value in | US$ 74.74 billion in 2021 |
| Market Size Value by | US$ 150.65 billion by 2028 |
| Growth rate | CAGR of 10.5% from 2021 to 2028 |
| Forecast Period | 2021- 2028 |
| Base Year | 2021 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
However, there was an unusual demand for Remdesivir, an antiviral medicine used to treat patients, when the outbreak was at its peak. Thus, manufacturers in the generic injectables market are now prepared for the future as they focus on keeping adequate stock for keeping supply chain operations unaffected dur to any type of vulnerabilities. Gilead Sciences and other big pharma companies, for example, have reduced the prices of their generic versions of remdesivir considerably. Companies are utilizing government programs and financing schemes offered by the BFSI industries to streamline their operations. In May 2020, the US government entered into an agreement, worth US$ 812 million, with a group of American generic medicine manufacturers, with the goal of bolstering the country's drug supply amid the global COVID-19 pandemic.
Furthermore, the pandemic strained pharmaceutical industries globally, interrupting and delaying supply of various critical drugs. Many market players came to rescue with immediate actions. For instance, in January 2021, Civica Rx teamed up with the brand-new Phlow Corp. in an effort to support drug manufacturing in the US and supply critical medications to hospitals fighting the pandemic. Civica invested US$ 124.5 million in the construction of a sterile injectable manufacturing facility in Petersburg, Virginia, which rose to prominence last year owing to a large government contract to produce COVID-19-related drugs.
Based on region, the generic injectables market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America.
Market Insights
High Demand for Affordable Drugs Drives Generic Injectables Market
High Demand for Affordable Drugs Drives Generic Injectables Market
Innovator drugs are expensive owing to high investments made in the research & development of molecules; these drugs are specifically unaffordable for a large share of the population in developing countries. However, generic drugs are affordable and provide greater access to healthcare. As published by the Association for Accessible Medicines (AAM), the average primary copay (the amount set by the insurance plans) of a generic drug is US$ 6.06 and US$ 40.30 for branded drugs. This fact indicates the falling prices of generic medicines by at least ~7%. According to the American Association of Retired Person (AARP), branded drug prices continue to increase at a pace that is 100-times greater than inflation. Moreover, as mentioned by the USFDA, 9/10 prescriptions filled in the US are for generic drugs. Additionally, the generic drug’s average manufacturer prices (AMP) are ~39% lower than the branded drug’s AMP. For instance, as published by Association for Accessible Medicines (AAM), 93% of generic prescriptions are filled for US$ 20 or less. The facts mentioned above boost the demand and availability of generic injectables, thus driving the entry of more players into the generic injectables market.
Further, low prices of generic injectables contribute to greater and effective chronic illness treatments. As per the World Health Organization (WHO), ~422 million people worldwide were diabetic in 2021. Generic injectables such as insulin injections offer immediate solutions for such ailments, alongside ensuring affordable treatments in developing countries.
Product Type-Based Insights
Based on product type, the generic injectables market is segmented into large molecule injectables and small molecule injectables. In 2021, the large molecule injectables segment accounted for a greater market share. The market position of this segment is credited to a surge in the adoption of biologics in the healthcare sector, and the progress of monoclonal antibody and antibody-drug conjugates (ADCs) into the drug development.
Container Type-Based Insights
Based on container type, the generic injectables market is segmented into vials, premix, prefilled syringes, ampoules, and others. The vials segment is likely to dominate the market in 2021.
Application-Based Insights
The generic injectables market, based on application, has been categorized into oncology, infectious diseases, cardiology, diabetes, immunology, and others. The oncology segment is likely to hold the largest share of the market in 2021. An increase in cancer incidences and rise in the launch of drugs is anticipated drives the growth of the oncology market segment.
Generic Injectables Market Report Scope
Route of Administration-Based Insights
Based on the route of administration, the generic injectables market has been categorized into intravenous, intramuscular, subcutaneous, and others. The intravenous segment held the largest market share in 2021.
The generic injectables market players adopt organic strategies such as product launch and expansion to expand their footprint and product portfolio worldwide.
By Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
South and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- Astrazeneca
- Baxter International, Inc.
- Biocon
- Fresenius SE & Co. KGaA
- GlaxoSmithKline Plc
- Hikma Pharmaceuticals
- Johnson & Johnson Services, Inc.
- Lupin, Ltd.
- Merck & Co., Inc.
- Mylan N.V.
- Pfizer, Inc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Container Type, Application, and Route of Administration, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Global generic injectables market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for generic injectables market. The US is estimated to hold the largest share in the generic injectables market during the forecast period. The presence of top players and favorable regulations related to product approvals coupled with commercializing new products are the contributing factors for the regional growth. Additionally, the increasing number of technological advancements is the key factor responsible for the Asia-Pacific regional growth for generic injectables accounting fastest growth of the region during the coming years.
The oncology segment dominated the global generic injectables market and accounted for the largest revenue of 21.62 Bn in 2021.
Astrazeneca, Baxter International, Inc., Biocon, Fresenius SE & Co., KGaA, GlaxoSmithKline Plc, Hikma Pharmaceuticals, Johnson & Johnson Services, Inc., Lupin, Ltd., Merck & Co., Inc., Mylan N.V., Pfizer, Inc. are among the leading companies operating in the global generic injectables market
Generic Injectables are safe and effective innovator bio-equivalent drugs of their branded counterparts which are not protected by drug patents. They have a similar ingredient, dosage, strength, quality, form, etc.
High demand for affordable drugs is one of the most significant factors responsible for the overall market growth.
Based on product type, large molecule injectables took the forefront leaders in the worldwide market by accounting largest share in 2020 and is expected to continue to do so till the forecast period.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Generic injectables Market – By Product Type
1.3.2 Global Generic injectables Market – By Container Type
1.3.3 Global Generic injectables Market – By Application
1.3.4 Global Generic injectables Market – By Route of Administration
1.3.5 Global Generic injectables Market – By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Generic Injectables Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East And Africa PEST Analysis
4.2.5 South And Central America PEST Analysis
4.3 Experts Opinion
5. Generic Injectables Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Low R&D, Marketing, and Manufacturing Costs
5.1.2 High Demand for Affordable Drugs
5.2 Market Restraints
5.2.1 Critical Inspection System for Prefilled Injection
5.3 Market Opportunities
5.3.1 Increasing Patent Expiry of Drugs
5.4 Future Trends
5.4.1 Government Support for Generic Injectables Production and Healthcare Cost Reduction
5.5 Impact Analysis
6. Generic Injectables Market– Global Analysis
6.1 Global Generic Injectables Market Revenue Forecast and Analysis
6.2 Global Generic Injectables Market Revenue Forecast and Analysis
6.3 Market Positioning of Key Players
7. Global Generic Injectables Market Revenue and Forecast To 2028– by Product Type
7.1 Overview
7.2 Global Generic Injectables Market, By Product Type, 2021 & 2028 (%)
7.3 Large Molecule Injectables
7.3.1 Overview
7.3.2 Large Molecule Injectables: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
7.4 Small Molecule Injectables
7.4.1 Overview
7.4.2 Small Molecule Injectables: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
8. Global Generic Injectables Market Revenue and Forecast To 2028– by Container Type
8.1 Overview
8.2 Global Generic Injectables Market, By Container Type, 2021 & 2028 (%)
8.3 Vials
8.3.1 Overview
8.3.2 Vials: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
8.4 Premix
8.4.1 Overview
8.4.2 Premix: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
8.5 Prefilled Syringes
8.5.1 Overview
8.5.2 Prefilled Syringes: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
8.6 Ampoules
8.6.1 Overview
8.6.2 Ampoules: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
9. Global Generic Injectables Market Revenue and Forecast To 2028– by Application
9.1 Overview
9.2 Global Generic Injectables Market, By Application, 2021 & 2028 (%)
9.3 Oncology
9.3.1 Overview
9.3.2 Oncology: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
9.4 Infectious Diseases
9.4.1 Overview
9.4.2 Infectious Diseases: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
9.5 Cardiology
9.5.1 Overview
9.5.2 Cardiology: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
9.6 Diabetes
9.6.1 Overview
9.6.2 Diabetes: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
9.7 Immunology
9.7.1 Overview
9.7.2 Immunology: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
10. Global Generic Injectables Market Revenue and Forecast To 2028– by Route of Administration
10.1 Overview
10.2 Global Generic Injectables Market, By Route of Administration, 2021 & 2028 (%)
10.3 Intravenous
10.3.1 Overview
10.3.2 Intravenous: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
10.4 Intramuscular
10.4.1 Overview
10.4.2 Intramuscular: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
10.5 Subcutaneous
10.5.1 Overview
10.5.2 Subcutaneous: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
11. Generic Injectables Market Revenue and Forecast to 2028 – Geographical Analysis
11.1 North America: Generic Injectables Market Revenue and Forecast to 2028
11.1.1 Overview
11.1.2 North America: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.1.3 North America: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)
11.1.4 North America: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)
11.1.5 North America: Generic Injectables Market, by Application, 2019–2028 (USD Million)
11.1.6 North America: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)
11.1.7 North America: Generic Injectables Market, by Country, 2020 & 2028 (%)
11.1.7.1 US: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.1 US: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.1.2 US: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)
11.1.7.1.3 US: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)
11.1.7.1.4 US: Generic Injectables Market, by Application, 2019–2028 (USD Million)
11.1.7.1.5 US: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)
11.1.7.2 Canada: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.1 Canada: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.2.2 Canada: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)
11.1.7.2.3 Canada: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)
11.1.7.2.4 Canada: Generic Injectables Market, by Application, 2019–2028 (USD Million)
11.1.7.2.5 Canada: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)
11.1.7.3 Mexico: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.1 Mexico: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.1.7.3.2 Mexico: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)
11.1.7.3.3 Mexico: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)
11.1.7.3.4 Mexico: Generic Injectables Market, by Application, 2019–2028 (USD Million)
11.1.7.3.5 Mexico: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)
11.2 Europe: Generic Injectables Market
11.2.1 Overview
11.2.2 Europe: Generic Injectables Market - Revenue and Forecast to 2028 (US$ Million)
11.2.3 Europe: Generic Injectables Market, Revenue and Forecast to 2028, By Product Type (US$ Million)
11.2.4 Europe: Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)
11.2.5 Europe: Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)
11.2.6 Europe: Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)
11.2.7 Europe: Generic Injectables Market, Revenue and Forecast to 2028, By Country (%)
11.2.7.1 Germany: Generic Injectables Market -Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.1 Germany: Generic Injectables Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.2 Germany: Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)
11.2.7.1.3 Germany: Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)
11.2.7.1.4 Germany: Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)
11.2.7.1.5 Germany: Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)
11.2.7.2 France: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.1 France: Generic Injectables Market - Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.2 France: Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)
11.2.7.2.3 France: Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)
11.2.7.2.4 France: Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)
11.2.7.2.5 France: Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)
11.2.7.3 UK: Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.1 UK: Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.2 UK: Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)
11.2.7.3.3 UK: Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)
11.2.7.3.4 UK: Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)
11.2.7.3.5 UK: Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)
11.2.7.4 Italy: Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.1 Italy: Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.2 Italy: Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)
11.2.7.4.3 Italy: Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)
11.2.7.4.4 Italy: Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)
11.2.7.4.5 Italy: Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)
11.2.7.5 Spain: Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.1 Spain: Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.2 Spain: Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)
11.2.7.5.3 Spain: Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)
11.2.7.5.4 Spain: Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)
11.2.7.5.5 Spain: Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)
11.2.7.6 Rest of Europe: Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.1 Rest of Europe: Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.2 Rest of Europe: Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)
11.2.7.6.3 Rest of Europe: Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)
11.2.7.6.4 Rest of Europe: Product Type Market- Revenue and Forecast to 2028, By Application (US$ Million)
11.2.7.6.5 Rest of Europe: Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)
11.3 Asia Pacific: Generic Injectables Market
11.3.1 Overview
11.3.2 Asia Pacific: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
11.3.3 Asia Pacific: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)
11.3.4 Asia Pacific: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)
11.3.5 Asia Pacific: Generic Injectables Market, by Application, 2019–2028 (USD Million)
11.3.6 Asia Pacific: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)
11.3.7 Asia Pacific: Generic Injectables Market, by Country, 2021 & 2028 (%)
11.3.7.1 China: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.1.1 China: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.1.2 China: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)
11.3.7.1.3 China: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)
11.3.7.1.4 China: Generic Injectables Market, by Application, 2019–2028 (USD Million)
11.3.7.1.5 China: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)
11.3.7.2 Japan: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.2.1 Japan: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.2.2 Japan: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)
11.3.7.2.3 Japan: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)
11.3.7.2.4 Japan: Generic Injectables Market, by Application, 2019–2028 (USD Million)
11.3.7.2.5 Japan: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)
11.3.7.3 India: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.3.1 India: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.3.2 India: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)
11.3.7.3.3 India: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)
11.3.7.3.4 India: Generic Injectables Market, by Application, 2019–2028 (USD Million)
11.3.7.3.5 India: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)
11.3.7.4 Australia: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.4.1 Australia: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.4.2 Australia: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)
11.3.7.4.3 Australia: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)
11.3.7.4.4 Australia: Generic Injectables Market, by Application, 2019–2028 (USD Million)
11.3.7.4.5 Australia: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)
11.3.7.5 South Korea: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.5.1 South Korea: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.5.2 South Korea: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)
11.3.7.5.3 South Korea: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)
11.3.7.5.4 South Korea: Generic Injectables Market, by Application, 2019–2028 (USD Million)
11.3.7.5.5 South Korea: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)
11.3.7.6 Rest of Asia Pacific: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.6.1 Rest of Asia Pacific: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.3.7.6.2 Rest of Asia Pacific: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)
11.3.7.6.3 Rest of Asia Pacific: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)
11.3.7.6.4 Rest of Asia Pacific: Generic Injectables Market, by Application, 2019–2028 (USD Million)
11.3.7.6.5 Rest of Asia Pacific: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)
11.4 Middle East and Africa: Generic Injectables Market
11.4.1 Overview
11.4.2 Middle East & Africa: Generic Injectables Market - Revenue and Forecast to 2028 (US$ Million)
11.4.3 Middle East & Africa Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
11.4.4 Middle East & Africa: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)
11.4.5 Middle East & Africa: Generic Injectables Market, by Application, 2019–2028 (USD Million)
11.4.6 Middle East & Africa: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)
11.4.7 Middle East & Africa: Generic Injectables Market, by Country, 2021 & 2028 (%)
11.4.7.1 Saudi Arabia: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
11.4.7.1.1 Saudi Arabia: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.1.2 Saudi Arabia Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
11.4.7.1.3 Saudi Arabia: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)
11.4.7.1.4 Saudi Arabia: Generic Injectables Market, by Application, 2019–2028 (USD Million)
11.4.7.1.5 Saudi Arabia: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)
11.4.7.2 UAE: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.2.1 UAE: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.2.2 UAE Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
11.4.7.2.3 UAE: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)
11.4.7.2.4 UAE: Generic Injectables Market, by Application, 2019–2028 (USD Million)
11.4.7.2.5 UAE: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)
11.4.7.3 South Africa: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.3.1 South Africa: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.4.7.3.2 South Africa Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
11.4.7.3.3 South Africa: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)
11.4.7.3.4 South Africa: Generic Injectables Market, by Application, 2019–2028 (USD Million)
11.4.7.3.5 South Africa: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)
11.4.7.4 Rest of Middle East and Africa: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
11.4.7.4.1 Rest of Middle East and Africa: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
11.4.7.4.2 Rest of Middle East & Africa Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
11.4.7.4.3 Rest of Middle East & Africa: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)
11.4.7.4.4 Rest of Middle East & Africa: Generic Injectables Market, by Application, 2019–2028 (USD Million)
11.4.7.4.5 Rest of Middle East & Africa: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)
11.5 South and Central America: Generic Injectables Market Revenue and Forecast to 2028
11.5.1 South and Central America: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.5.2 South and Central America: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)
11.5.3 South and Central America: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)
11.5.4 South and Central America: Generic Injectables Market, by Application, 2019–2028 (USD Million)
11.5.5 South and Central America: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)
11.5.6 South and Central America: Generic Injectables Market, by Country, 2020 & 2028 (%)
11.5.6.1 Brazil: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.5.6.1.1 Brazil: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.5.6.1.2 Brazil: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)
11.5.6.1.3 Brazil: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)
11.5.6.1.4 Brazil: Generic Injectables Market, by Application, 2019–2028 (USD Million)
11.5.6.1.5 Brazil: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)
11.5.6.2 Argentina: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.5.6.2.1 Argentina: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.5.6.2.2 Argentina: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)
11.5.6.2.3 Argentina: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)
11.5.6.2.4 Argentina: Generic Injectables Market, by Application, 2019–2028 (USD Million)
11.5.6.2.5 Argentina: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)
11.5.6.3 Rest of South and Central America: Generic Injectables Market- Revenue and Forecast to 2027 (USD Million)
11.5.6.3.1 Rest of South and Central America: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
11.5.6.3.2 Rest of South and Central America: Generic Injectables Market, by Product Type, 2019–2028 (USD Million)
11.5.6.3.3 Rest of South and Central America: Generic Injectables Market, by Container Type, 2019–2028 (USD Million)
11.5.6.3.4 Rest of South and Central America: Generic Injectables Market, by Application, 2019–2028 (USD Million)
11.5.6.3.5 Rest of South and Central America: Generic Injectables Market, by Route of Administration, 2019–2028 (USD Million)
12. Impact Of COVID-19 Pandemic on Generic Injectables Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 MEA: Impact Assessment of COVID-19 Pandemic
12.5 South and Central America: Impact Assessment of COVID-19 Pandemic
13. Generic Injectables Market– Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 AstraZeneca
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Baxter International Inc.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Biocon
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Fresenius SE & Co. KGaA
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 GlaxoSmithKline plc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Hikma Pharmaceuticals PLC
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Johnson and Johnson Services, Inc.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Lupin
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Viatris Inc.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Merck & Co., Inc.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Pfizer Inc.
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 2. North America Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)
Table 3. North America Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. North America Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 5. US Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 6. US Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)
Table 7. US Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 8. US Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 9. Canada Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 10. Canada Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)
Table 11. Canada Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 12. Canada Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 17. Europe Generic Injectables Market Revenue and Forecast to 2028, By Product Type (US$ Million).
Table 18. Europe Generic Injectables Market - Revenue and Forecast to 2028, By Container Type (US$ Million)
Table 19. Europe Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)
Table 20. Europe Generic Injectables Market - Revenue and Forecast to 2028, By Route of Administration (US$ Million)
Table 21. Germany Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)
Table 22. Germany Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)
Table 23. Germany Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)
Table 24. Germany Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)
Table 25. France Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)
Table 26. France Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)
Table 27. France Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)
Table 28. UK Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)
Table 29. UK: Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)
Table 30. UK Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)
Table 31. UK: Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)
Table 32. Italy: Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)
Table 33. Italy Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)
Table 34. Italy Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)
Table 35. Italy Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)
Table 36. Spain Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)
Table 37. Spain Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)
Table 38. Spain Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)
Table 39. Spain Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)
Table 40. Rest of Europe: Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)
Table 41. Rest of Europe: Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)
Table 42. Rest of Europe Product Type Market- Revenue and Forecast to 2028, By Application (US$ Million)
Table 43. Rest of Europe: Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)
Table 44. Asia Pacific Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 45. Asia Pacific Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)
Table 46. Asia Pacific Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 47. Asia Pacific Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 48. China Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 49. China Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)
Table 50. China Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 51. China Pacific Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 52. Japan Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 53. Japan Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)
Table 54. Japan Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 55. Japan Pacific Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 56. India Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 57. India Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)
Table 58. India Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 59. India Pacific Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 60. Australia Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 61. Australia Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)
Table 62. Australia Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 63. Australia Pacific Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 64. South Korea Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 65. South Korea Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)
Table 66. South Korea Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 67. South Korea Pacific Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 68. Rest of Asia Pacific Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 69. Rest of Asia Pacific Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)
Table 70. Rest of Asia Pacific Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 71. Rest of Asia Pacific Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 72. Middle East & Africa Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 73. Middle East & Africa Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)
Table 74. Middle East & Africa Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 75. Middle East & Africa Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 76. Saudi Arabia Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 77. Saudi Arabia Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)
Table 78. Saudi Arabia Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 79. Saudi Arabia Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 80. UAE Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 81. UAE Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)
Table 82. UAE Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 83. UAE Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 84. South Africa Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 85. South Africa Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)
Table 86. South Africa Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 87. South Africa Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 88. Rest of Middle East & Africa Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 89. Rest of Middle East & Africa Generic Injectables Market, by Container Type– Revenue and Forecast to 2028 (USD Million)
Table 90. Rest of Middle East & Africa Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 91. Rest of Middle East & Africa Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 92. South and Central America Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 93. South and Central America Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)
Table 94. South and Central America Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 95. South and Central America Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 96. Brazil Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 97. Brazil Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)
Table 98. Brazil Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 99. Brazil Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 100. Argentina Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 101. Argentina Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)
Table 102. Argentina Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 103. Argentina Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 104. Rest of South and Central America Generic Injectables Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 105. Rest of South and Central America Generic Injectables Market, by Container Type – Revenue and Forecast to 2028 (USD Million)
Table 106. Rest of South and Central America Generic Injectables Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 107. Rest of South and Central America Generic Injectables Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)
Table 108. Organic Developments Done By Companies
Table 109. Inorganic Developments Done By Companies
Table 110. Glossary of Terms, Generic Injectables Market
LIST OF FIGURES
Figure 1. Generic injectables Market Segmentation
Figure 2. Generic injectables Market, By Region
Figure 3. Global Generic Injectables Market Overview
Figure 4. Large Molecule Injectable Segment Held Largest Share of Product Type Segment in Generic injectables Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Generic Injectables Market, by Geography (US$ Million)
Figure 7. Global Generic Injectables Market- Leading Country Markets (US$ Million)
Figure 8. Global Generic injectables Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East And Africa: PEST Analysis
Figure 13. South And Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Generic injectables Market Impact Analysis of Driver and Restraints
Figure 16. Global Generic injectables Market– Revenue Forecast and Analysis – 2020- 2028
Figure 17. Global Generic Injectables Market– Revenue Forecast and Analysis – 2021 - 2028
Figure 18. Market Positioning of Key Players in Global Generic injectables Market
Figure 19. Global Generic Injectables Market, by Product Type, 2021 & 2028 (%)
Figure 20. Large Molecule Injectables: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 21. Small Molecule Injectables: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 22. Global Generic Injectables Market, by Container Type, 2021 & 2028 (%)
Figure 23. Vials: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 24. Premix: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 25. Prefilled Syringes: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 26. Ampoules: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 27. Others: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 28. Global Generic Injectables Market, by Application, 2021 & 2028 (%)
Figure 29. Oncology: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 30. Infectious Diseases: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 31. Cardiology: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 32. Diabetes: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 33. Immunology: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 34. Others: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 35. Global Generic Injectables Market, by Route of Administration, 2021 & 2028 (%)
Figure 36. Intravenous: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 37. Intramuscular: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 38. Subcutaneous: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 39. Others: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 40. North America: Generic Injectables Market, by Key Country – Revenue (2021) (USD Million)
Figure 41. North America Generic Injectables Market Revenue and Forecast to 2028 (USD Million)
Figure 42. North America: Generic Injectables Market, by Country, 2020 & 2028 (%)
Figure 43. US: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
Figure 44. Canada: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
Figure 45. Mexico: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
Figure 46. Europe: Generic Injectables Market, Revenue Overview, by Country, 2021 (US$ Million)
Figure 47. Europe: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
Figure 48. Europe Generic Injectables Market, Revenue and Forecast to 2028, By Country (%)
Figure 49. Germany Generic Injectables Market - Revenue and Forecast to 2028 (US$ Million)
Figure 50. France: Generic Injectables Market - Revenue and Forecast to 2028 (US$ Million)
Figure 51. UK: Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)
Figure 52. Italy: Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)
Figure 53. Spain: Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)
Figure 54. Rest of Europe: Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)
Figure 55. Asia Pacific: Generic Injectables Market, by Key Country – Revenue (2021) (USD Million)
Figure 56. Asia Pacific Generic Injectables Market Revenue and Forecast to 2028 (USD Million)
Figure 57. China: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
Figure 58. Japan: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
Figure 59. India: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
Figure 60. Australia: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
Figure 61. South Korea: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
Figure 62. Rest of Asia Pacific: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
Figure 63. Middle East & Africa: Generic Injectables Market, by Key Country – Revenue (2021) (USD Million)
Figure 64. Middle East & Africa Generic Injectables Market Revenue and Forecast to 2028 (USD Million)
Figure 65. Middle East & Africa: Generic Injectables Market, by Country, 2021 & 2028 (%)
Figure 66. Saudi Arabia: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
Figure 67. UAE: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
Figure 68. South Africa: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
Figure 69. Rest of Middle East and Africa: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
Figure 70. South and Central America: Generic Injectables Market, by Key Country – Revenue (2021) (USD Million)
Figure 71. South and Central America Generic Injectables Market Revenue and Forecast to 2028 (USD Million)
Figure 72. South and Central America: Generic Injectables Market, by Country, 2020 & 2028 (%)
Figure 73. Brazil: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
Figure 74. Argentina: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
Figure 75. Rest of South and Central America: Generic Injectables Market – Revenue and Forecast to 2028 (USD Million)
Figure 76. Impact of COVID-19 Pandemic in North America Country Markets
Figure 77. Impact of COVID-19 Pandemic in European Country Markets
Figure 78. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 79. Impact of COVID-19 Pandemic on Middle East & Africa Country Markets
Figure 80. Impact of COVID-19 Pandemic in South and Central America Country Market
Figure 81. Growth Strategies Done by the Companies in the Market
The List of Companies - Generic Injectables Market
- Astrazeneca
- Baxter International, Inc.
- Biocon
- Fresenius SE & Co. KGaA
- GlaxoSmithKline Plc
- Hikma Pharmaceuticals
- Johnson & Johnson Services, Inc.
- Lupin, Ltd.
- Merck & Co., Inc.
- Mylan N.V.
- Pfizer, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For